Business Wire

Aphton and SmithKline Beecham Form Strategic Alliance.

Business Wire | June 19, 1998 | Copyright

MIAMI--(BW HealthWire)--June 19, 1998--Aphton Corporation (NASDAQ:APHT) and SmithKline Beecham today announced the signing of a Collaboration and License Agreement for a worldwide strategic alliance for Aphton's Gonadimmune(TM) anti-Gonadotropin Releasing Hormone (anti-GnRH) vaccines.

The agreement covers the diagnosis, treatment and prevention of GnRH-related cancers and other diseases in humans - including - prostate, breast, ovarian and endometrial cancers; and endometriosis, polycystic ovaries, uterine fibroids, contraception, infertility and precocious puberty.…

Read the rest of this article with a FREE trial to HighBeam Research

Related newspaper, magazine, and trade journal articles from HighBeam Research

(Including press releases, facts, information, and biographies)

Aphton and SmithKline Beecham Form Strategic Alliance.
Business Wire ...June 19, 1998--Aphton Corporation (NASDAQ:APHT) and SmithKline Beecham today announced the...Agreement for a worldwide strategic alliance for Aphton's Gonadimmune...of the agreement, SmithKline Beecham will receive exclusive...

For more facts and information, see all results

Find more facts and information related to the article Aphton and SmithKline Beecham Form Strategic ...